Although their contribution to host defense against extracellular
infections has been well defined,
IL-17 and Th17 are generally thought to have limited impact on intracellular
infections. In this study, we investigated the role and mechanisms of IL-17/Th17 in host defense against Chlamydia muridarum, an obligate intracellular bacterium, lung
infection. Our data showed rapid increase in
IL-17 production and expansion of Th17 cells following C. muridarum
infection and significant detrimental impact of in vivo
IL-17 neutralization by anti-IL-17 mAb on disease course, immune response, and dendritic cell (DC) function. Specifically, IL-17-neutralized mice exhibited significantly greater
body weight loss, higher organism growth, and much more severe pathological changes in the lung compared with
sham-treated control mice. Immunological analysis showed that
IL-17 neutralization significantly reduced Chlamydia-specific Th1 responses, but increased Th2 responses. Interestingly, the DC isolated from IL-17-neutralized mice showed lower CD40 and MHC II expression and
IL-12 production, but higher
IL-10 production compared with those from
sham-treated mice. In two DC-T cell coculture systems, DC isolated from IL-17-neutralized mice induced higher
IL-4, but lower IFN-gamma production by Ag-specific T cells than those from
sham-treated mice in cell priming and reaction settings. Adoptive transfer of DC isolated from IL-17-neutralized mice, unlike those from
sham-treated mice, failed to protect the recipients against challenge
infection. These findings provide in vivo evidence that IL-17/Th17 plays an important role in host defense against intracellular
bacterial infection, and suggest that IL-17/Th17 can promote type 1 T cell immunity through modulating DC function.